Your DNA Holds Answers. Your Health App Should Too.

Your MTHFR gene encodes an enzyme that converts dietary folate and other B vitamins into the active forms your cells can actually use. This isn’t a optional process. Every cell in your body depends on it. Your mitochondria depend on it. Your neurons depend on it. Your energy production depends on it.

Here’s the problem: the MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces this enzyme’s efficiency by 40-70%. That means your cells are converting B vitamins into usable energy at a fraction of the rate they should be. You can eat a perfect diet and still be functionally depleted at the cellular level. Your bloodwork shows normal folate and B12 levels because standard blood tests measure inactive forms. Your cells are still starving.

The consequence shows up as relentless fatigue, poor recovery from exercise, brain fog that coffee doesn’t touch, and mood instability that no amount of sleep seems to fix. You feel like you should have more energy than you do. Your body is working harder than it should have to, just to convert the nutrients you’re eating into usable forms.

Your VDR gene encodes the receptor that allows cells to actually use vitamin D. Vitamin D isn’t just about bone health or immune function. Your mitochondria need it. Your sleep-wake cycle depends on it. Your energy production is controlled by it. Without functional vitamin D signaling, your cells can’t make ATP efficiently.

The VDR variants, present in roughly 30-50% of people, reduce how effectively your cells can absorb and respond to vitamin D. This means you can have high blood levels of vitamin D and still be vitamin D deficient at the cellular level. Your standard doctor will see your blood test and tell you your vitamin D is fine. Your mitochondria know it isn’t. This is why some people supplement vitamin D aggressively and still feel exhausted.

You notice this as persistent fatigue despite adequate sleep, weakness in your legs and core, difficulty building muscle even with consistent training, and a general sense that your body isn’t responding the way it should. Your circadian rhythm feels off. Your energy dips in ways that seem disconnected from what you’ve done that day.

Your BRCA1 gene is a tumor suppressor. Its job is to repair DNA damage before it turns into cancer. Every cell has BRCA1. Every day it’s working to catch and fix mutations before they accumulate. If BRCA1 isn’t working properly, those mutations keep building up.

Certain BRCA1 variants, especially pathogenic mutations, significantly increase lifetime risk for breast and ovarian cancer. The prevalence of pathogenic BRCA1 variants is roughly 1 in 400-500 in European ancestry populations, though much higher in Ashkenazi Jewish populations. Pathogenic BRCA1 variants aren’t a guarantee of cancer. They are a signal that your body is less able to repair DNA damage before it becomes dangerous. This means your screening strategy and preventive approach need to be fundamentally different from someone without the variant.

If you carry a BRCA1 variant, you’re not doomed. You’re informed. You know your risk profile. You can adopt screening protocols that catch problems early, make choices about hormone therapy and preventive medications that make sense for your biology, and take specific actions to reduce the things that accelerate DNA damage in your system.

Your BRCA2 gene does similar DNA repair work to BRCA1, but with a slightly different scope. BRCA2 variants increase risk for breast, ovarian, and pancreatic cancer, and also elevate prostate cancer risk in men. Like BRCA1, BRCA2 works silently until it doesn’t, repairing DNA damage constantly in ways you never notice.

Pathogenic BRCA2 variants appear in roughly 1 in 400-500 people in European ancestry populations. BRCA2 variants often carry different risk profiles than BRCA1, with somewhat lower ovarian cancer risk but significant pancreatic cancer risk. This distinction matters because it shapes which screening protocols make sense for you. A pathogenic BRCA2 variant means your preventive strategy needs to include pancreatic screening and earlier, more aggressive breast imaging.

You may not feel any different carrying a BRCA2 variant. The impact is on your lifetime risk trajectory and your ability to catch problems early. You’re living in a body that’s slightly less able to prevent mutations from accumulating. The intervention isn’t medication or supplements. It’s information and proactive screening.

Your CYP2D6 gene encodes an enzyme that metabolizes roughly 25% of all prescription medications. Antidepressants, pain medications, beta-blockers, antiarrhythmics, antihistamines. If your body is going to process a drug, CYP2D6 is probably involved. This single gene is the reason why two people on the same dose of the same medication can have completely different experiences.

CYP2D6 comes in many variants. Some people are ultra-rapid metabolizers, clearing drugs so quickly that standard doses don’t work. Some are normal metabolizers. Some are intermediate metabolizers. Roughly 7-10% of European ancestry populations are ultra-rapid metabolizers, and roughly 5-10% are poor metabolizers. Your metabolizer status can mean the difference between a medication working perfectly, doing nothing, or causing dangerous side effects at standard doses. Your doctor has no way of knowing without testing.

You’ve likely noticed this if you’ve ever been prescribed a psychiatric medication or pain reliever. You feel nothing at the dose your doctor prescribed, so they increase it. Then suddenly you feel everything: nausea, dizziness, brain fog, emotional blunting. Or you try a medication that works great for your friend and it makes you feel terrible. Your CYP2D6 status explains all of this. It’s not the medication. It’s your genes.

Your APOE gene encodes apolipoprotein E, a protein that carries cholesterol through your bloodstream and plays a critical role in brain cell repair and cognitive function. This isn’t just a cholesterol gene. It’s a brain aging gene. Your APOE status shapes your lifetime risk for cognitive decline, Alzheimer’s disease, and how your brain recovers from injury.

APOE comes in three main versions: e2, e3, and e4. Roughly 60-70% of people carry at least one e3 allele, but about 15-25% carry the e4 variant, which is associated with higher Alzheimer’s risk and higher cholesterol levels. Carrying even one APOE e4 allele increases Alzheimer’s risk roughly three-fold. Carrying two copies increases it by 10-fold or more. This doesn’t mean you will get Alzheimer’s. It means your brain needs more aggressive cognitive and metabolic protection than someone with the e3 or e2 variants.

If you carry APOE e4, you’ve probably noticed that brain fog hits differently. Inflammation seems to affect your cognition faster. You recover from sleep deprivation more slowly. You might have higher cholesterol despite eating well. Your risk profile for age-related cognitive decline is steeper. This isn’t a life sentence. It’s a wake-up call. Your brain needs more preventive support than average.